Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Christina WarneckeKai-Uwe Eckardt

Abstract

Activation of the hypoxia-inducible factor alpha-subunits, HIF-1alpha and HIF-2alpha, seems to be subject to similar regulatory mechanisms, and transgene approaches suggested partial functional redundancy. Here, we used RNA interference to determine the contribution of HIF-1alpha vs. HIF-2alpha to the hypoxic gene induction. Surprisingly, most genes tested were responsive only to the HIF-1alpha siRNA, showing no effect by HIF-2alpha knock-down. The same was found for the activation of reporter genes driven by hypoxia-responsive elements (HREs) from the erythropoietin (EPO), vascular endothelial growth factor, or phosphoglycerate kinase gene. Interestingly, EPO was the only gene investigated that showed responsiveness only to HIF-2alpha knock-down, as observed in Hep3B and Kelly cells. In contrast to the EPO-HRE reporter, the complete EPO enhancer displayed dependency on HIF-2alpha regulation, indicating that additional cis-acting elements confer HIF-2alpha specificity within this region. In 786-0 cells lacking HIF-1alpha protein, the identified HIF-1alpha target genes were regulated by HIF-2alpha. Overexpression of the HIFalpha subunits in different cell lines also led to a loss of target gene specificity. In conclusion, we fou...Continue Reading

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M A GoldbergH F Bunn
Feb 1, 1988·The Journal of Clinical Investigation·C LacombeP Tambourin
Aug 1, 1995·Nature Medicine·O IliopoulosW G Kaelin
Jul 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·J PengG H Fong
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D M StrokaD Candinas
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hao ZhuH Franklin Bunn
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Jun 11, 2002·Methods : a Companion to Methods in Enzymology·Sayda M ElbashirThomas Tuschl
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Christian RosenbergerKai-Uwe Eckardt
Aug 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Roland H Wenger
Oct 11, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Amanda W WyattGiovanni E Mann
Dec 20, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Michael S WiesenerKai-Uwe Eckardt
Feb 28, 2003·The EMBO Journal·Masanobu MoritaYoshiaki Fujii-Kuriyama
Jul 30, 2003·The Journal of Biological Chemistry·Martin O LeonardCormac T Taylor
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Patrick Maxwell
Dec 19, 2003·Biochemical and Biophysical Research Communications·Jörg HänzeFrank Rose

❮ Previous
Next ❯

Citations

Jan 6, 2010·EMBO Molecular Medicine·Roxana I SufanMichael Ohh
Mar 12, 2011·European Journal of Applied Physiology·Mona MomeniGiuseppe Liistro
Oct 7, 2005·Pflügers Archiv : European journal of physiology·Carsten WillamKai-Uwe Eckardt
Aug 8, 2009·Cell and Tissue Research·Johanna Myllyharju, Ernestina Schipani
Oct 24, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·David R Mole, Peter J Ratcliffe
Apr 7, 2007·Cancer Metastasis Reviews·Jung-whan KimChi V Dang
Mar 13, 2012·Journal of Bioenergetics and Biomembranes·Céline PinheiroFátima Baltazar
Dec 2, 2008·Expert Reviews in Molecular Medicine·Constance Tom NoguchiYi Jia
Feb 9, 2008·Cell Death and Differentiation·S A Patel, M C Simon
Jan 26, 2008·Cell Death and Differentiation·P P Kapitsinou, V H Haase
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Aftab AhmadCarl W White
Feb 25, 2011·The Journal of Biological Chemistry·Rui ChenJoseph A Garcia
Jul 19, 2012·The Journal of Biological Chemistry·Rui ChenJoseph A Garcia
Mar 29, 2008·The Journal of Biological Chemistry·Yutaka MaedaJeffrey A Whitsett
Aug 14, 2013·Journal of the National Cancer Institute·Ivana JochmanováKarel Pacak
Jul 12, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Zhendi WangWanja M Bernhardt
Mar 9, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Xiaofang YuXiaoqiang Ding
Apr 1, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anthony J FilianoGail V W Johnson
Mar 3, 2009·Seminars in Dialysis·Theodoros EleftheriadisIoannis Stefanidis
Oct 20, 2005·Science's STKE : Signal Transduction Knowledge Environment·Roland H WengerGieri Camenisch
May 8, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Obinna I NdubuizuJoseph C LaManna
May 7, 2010·American Journal of Physiology. Renal Physiology·Volker H Haase
May 9, 2012·Anatomy Research International·Mawadda AlnaeeliConstance Tom Noguchi
Mar 3, 2006·The Journal of Clinical Investigation·Madhu P MenonDon M Wojchowski
Apr 4, 2007·The Journal of Clinical Investigation·Erinn B RankinVolker H Haase
Apr 4, 2007·The Journal of Clinical Investigation·Peter J Ratcliffe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.